UCB SA
EBR:UCB.BR
Overview | Financials
Company Name | UCB SA |
Symbol | UCB.BR |
Currency | EUR |
Price | 176.7 |
Market Cap | 33,523,537,429 |
Dividend Yield | 1.11% |
52-week-range | 65.4 - 176.7 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jean-Christophe Tellier |
Website | https://www.ucb.com |
An error occurred while fetching data.
About UCB SA
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD